GSK PERK Inhibitor-d3
实时
已添加到 RFQ
仅供研究与分析用途。不可个人使用。
包装与处理
所示为供视觉参考的示意性产品包装。实际包装可能因包装规格、数量、储存条件和运输要求而异。
可提供文档
可应要求提供详细规格、证书和支持性文件。
可应要求提供详细规格、证书和支持性文件。
储存： 完整信息请参阅 MSDS。
危害： 完整信息请参阅 MSDS。
GSK PERK Inhibitor-d3 产品信息
GSK PERK Inhibitor-d3 归类于 Stable Isotopes，用于分析研究、质量控制和药物对照品应用。 本产品由 Clearsynth 提供，目录号为 CS-T-98654.
Clearsynth 提供该化合物用于研究和分析用途，产品信息包括 CAS 号、分子式、分子量和产品咨询详情。
技术数据
产品名称
GSK PERK Inhibitor-d3
CAT 编号
CS-T-98654
HSN 代码
38229010
原产国
Can be shipped from India, Canada and USA
分子式
C24H16D3F4N5O
分子量
472.45
储存条件
完整信息请参阅 MSDS。
危险化合物
完整信息请参阅 MSDS。
描述
法规说明
GSK PERK Inhibitor-d3 is supplied with detailed characterization data compliant with regulatory guideline. GSK PERK Inhibitor-d3 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
概述
"Labelled GSK PERK Inhibitor is an inhibitors of PERK, an important transmembrane protein of endoplasmic reticulum (ER). GSK PERK Inhibitor can be useful in the treatment of cancer, ocular diseases, and diseases associated with activated unfolded protein response pathways. As a result, GSK PERK Inhibitor has potential use in the treatment of diseases such as Alzheimer's disease, stroke, Type 1 diabetes, Parkinson disease, Huntington's disease, amyotrophic lateral sclerosis, myocardial infarction, cardiovascular disease, atherosclerosis, and arrhythmias, and more specifically cancers of the breast, colon, pancreatic, and lung."
同义词
GSK PERK Inhibitor-d3
应用说明
"Labelled GSK PERK Inhibitor is an inhibitors of PERK, an important transmembrane protein of endoplasmic reticulum (ER). GSK PERK Inhibitor can be useful in the treatment of cancer, ocular diseases, and diseases associated with activated unfolded protein response pathways. As a result, GSK PERK Inhibitor has potential use in the treatment of diseases such as Alzheimer's disease, stroke, Type 1 diabetes, Parkinson disease, Huntington's disease, amyotrophic lateral sclerosis, myocardial infarction, cardiovascular disease, atherosclerosis, and arrhythmias, and more specifically cancers of the breast, colon, pancreatic, and lung."
产品应用与法规搜索词
此参考标准的有用产品、供应商和法规搜索词。